Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. antibiotic prescription
Show results for
Products
Software
Applications

Companies

News
Articles

Refine by
Date

  • Older

Antibiotic Prescription Articles & Analysis: Older

9 news found

MeMed raises $93M to accelerate commercialization of its  host immune-response product portfolio

MeMed raises $93M to accelerate commercialization of its host immune-response product portfolio

” Patrick Zhang, Horizons Ventures, said: “We strongly believe that MeMed’s strategy of using hostimmune response- technologies is a significant advance in the improvement of two major issues in healthcare today: the rise of antimicrobial resistance due to unnecessary prescription of antibiotics and effectively triaging patients infected with ...

ByMeMed


Clinical Data Published in Clinical Microbiology and Infection Support Use of MeMed’s Test in Reducing Antibiotic Overuse in Children

Clinical Data Published in Clinical Microbiology and Infection Support Use of MeMed’s Test in Reducing Antibiotic Overuse in Children

The test’s potential to improve antibiotic stewardship was demonstrated in children with fever without source and respiratory tract infections at emergency departments and wards in Italy and Germany. ...

ByMeMed


Inflammatix Secures $102 Million in Series D Financing Led by D1 Capital Partners to Commercialize Novel Host Response Diagnostics

Inflammatix Secures $102 Million in Series D Financing Led by D1 Capital Partners to Commercialize Novel Host Response Diagnostics

Sepsis caused more than five million deaths annually worldwide before the COVID-19 pandemic, and severe COVID-19 has been recognized as viral sepsis. In addition, antibiotic resistance is directly responsible for more than 700,000 deaths annually worldwide. ...

ByInflammatix, Inc.


BreathSpec and the fight against AMR

BreathSpec and the fight against AMR

This would better allow the right antibiotic to be prescribed to the right patient at the right time and in the right dose , thereby helping to minimise unnecessary prescription of antibiotics. ...

ByImspex Diagnostics Ltd.


OtoNexus Medical Technologies Wins 2020 Red Herring Top 100 North America Award

OtoNexus Medical Technologies Wins 2020 Red Herring Top 100 North America Award

As a result, middle ear infections are the #1 reason for antibiotic prescriptions and #1 reason for surgery in children. With the OtoNexus device, physicians can evaluate a middle ear infection and know whether antibiotic therapy is appropriate in less than 2 seconds. This definitive test will provide physicians the information they need to ...

ByOtoNexus Medical Technologies Inc.


OtoNexus Medical Technologies Wins Prestigious Most Valued Company Award at Keiretsu Forum Investor Capital Expo

OtoNexus Medical Technologies Wins Prestigious Most Valued Company Award at Keiretsu Forum Investor Capital Expo

As a result, middle ear infections are the #1 reason for antibiotic prescriptions and #1 reason for surgery in children. "Our goal is to decrease the usage of antibiotic therapy by 50% for the treatment of middle ear infections," said Caitlin Cameron, CEO OtoNexus Medical Technologies. ...

ByOtoNexus Medical Technologies Inc.


Thermo Fisher Scientific Supports Sepsis Awareness Month in September

Thermo Fisher Scientific Supports Sepsis Awareness Month in September

During this webinar listeners will learn the kinetics of PCT during infection, current biomarkers used in the management of bacterial infection, and how PCT can aid in antibiotic stewardship. Tuesday, September 24: We are sponsoring a webinar hosted by the Sepsis Alliance, "The Blind Spot of Antibiotic Stewardship: Antibiotic Overuse at ...

ByThermo Fisher Scientific, LIMS & Laboratory Software


Peer-Reviewed Clinical Study Shows ID Genomics’ Bacterial Fingerprinting Technology Can Reduce Prescription Errors and Antibiotic Overuse at the Point-of-Care

Peer-Reviewed Clinical Study Shows ID Genomics’ Bacterial Fingerprinting Technology Can Reduce Prescription Errors and Antibiotic Overuse at the Point-of-Care

SEATTLE (March 29, 2017) Newly published, peer-reviewed results of observational clinical research have demonstrated that ID Genomics’ “bacterial fingerprinting” technology has the potential to improve antibiotic prescribing, reducing prescription errors and the overuse of broad-spectrum antibiotics, which could ultimately ...

ByID Genomics Inc.


ID Genomics Awarded Prestigious Longitude Prize Discovery Award

ID Genomics Awarded Prestigious Longitude Prize Discovery Award

ID Genomics is developing innovative “bacterial fingerprinting” technology that has the potential to reduce prescription errors and the overuse of broad-spectrum antibiotics by improving the accuracy and speed of antibiotic prescribing process. ...

ByID Genomics Inc.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT